Moleculin Biotech, Inc. (MBRX) stock
MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.87−0.19 (-2.36%)
Close on Nov 13, 2026Market cap $8.23MP/E –Yield –
Moleculin Biotech total assets
Total assets on the balance sheet at the end of each period.
Moleculin Biotech's total assets was $20.74M at Sep 30, 2026. For fiscal 2025 it was $22.13M, up 30.7% from the year before. Over ten years it grew 94.8% a year on average. The highest annual figure on record is $84.09M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.13M | +30.7% |
| FY2024 | Dec 31, 2024 | $16.93M | -55.7% |
| FY2023 | Dec 31, 2023 | $38.22M | -33.4% |
| FY2022 | Dec 31, 2022 | $57.42M | -31.7% |
| FY2021 | Dec 31, 2021 | $84.09M | +189.7% |
| FY2020 | Dec 31, 2020 | $29.03M | +15.0% |
| FY2019 | Dec 31, 2019 | $25.24M | +28.8% |
| FY2018 | Dec 31, 2018 | $19.59M | +0.5% |
| FY2017 | Dec 31, 2017 | $19.48M | +18.8% |
| FY2016 | Dec 31, 2016 | $16.39M | +58256.8% |
| FY2015 | Dec 31, 2015 | $28.09K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $20.74M | +1.9% |
| Q2 FY2026 | Jun 30, 2026 | $21.09M | -2.3% |
| Q1 FY2026 | Mar 31, 2026 | $23.36M | +11.2% |
| Q4 FY2025 | Dec 31, 2025 | $22.13M | +30.7% |
| Q3 FY2025 | Sep 30, 2025 | $20.35M | -13.0% |
| Q2 FY2025 | Jun 30, 2025 | $21.59M | -15.6% |
| Q1 FY2025 | Mar 31, 2025 | $21.01M | -31.9% |
| Q4 FY2024 | Dec 31, 2024 | $16.93M | -55.7% |
| Q3 FY2024 | Sep 30, 2024 | $23.39M | -40.8% |
| Q2 FY2024 | Jun 30, 2024 | $25.58M | -45.7% |
| Q1 FY2024 | Mar 31, 2024 | $30.85M | -39.6% |
| Q4 FY2023 | Dec 31, 2023 | $38.22M | -33.4% |
| Q3 FY2023 | Sep 30, 2023 | $39.52M | -39.5% |
| Q2 FY2023 | Jun 30, 2023 | $47.12M | -35.7% |
| Q1 FY2023 | Mar 31, 2023 | $51.06M | -35.2% |
| Q4 FY2022 | Dec 31, 2022 | $57.42M | -31.7% |
| Q3 FY2022 | Sep 30, 2022 | $65.37M | -26.3% |
| Q2 FY2022 | Jun 30, 2022 | $73.26M | -21.7% |
| Q1 FY2022 | Mar 31, 2022 | $78.80M | -21.0% |
| Q4 FY2021 | Dec 31, 2021 | $84.09M | +189.7% |
| Q3 FY2021 | Sep 30, 2021 | $88.70M | +226.8% |
| Q2 FY2021 | Jun 30, 2021 | $93.53M | +198.1% |
| Q1 FY2021 | Mar 31, 2021 | $99.78M | +291.7% |
| Q4 FY2020 | Dec 31, 2020 | $29.03M | +15.0% |
| Q3 FY2020 | Sep 30, 2020 | $27.14M | -10.7% |
| Q2 FY2020 | Jun 30, 2020 | $31.38M | -1.5% |
| Q1 FY2020 | Mar 31, 2020 | $25.47M | +19.6% |
| Q4 FY2019 | Dec 31, 2019 | $25.24M | +28.8% |
| Q3 FY2019 | Sep 30, 2019 | $30.40M | +45.5% |
| Q2 FY2019 | Jun 30, 2019 | $31.85M | +32.4% |
| Q1 FY2019 | Mar 31, 2019 | $21.30M | -14.6% |
| Q4 FY2018 | Dec 31, 2018 | $19.59M | +0.5% |
| Q3 FY2018 | Sep 30, 2018 | $20.90M | +1.3% |
| Q2 FY2018 | Jun 30, 2018 | $24.07M | +13.3% |
| Q1 FY2018 | Mar 31, 2018 | $24.93M | +52.1% |
| Q4 FY2017 | Dec 31, 2017 | $19.48M | +10.9% |
| Q3 FY2017 | Sep 30, 2017 | $20.63M | – |
| Q2 FY2017 | Jun 30, 2017 | $21.25M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.39M | – |
| Q3 FY2016 | Sep 30, 2016 | $17.57M | – |
See a number that looks wrong?